TG-2349 not checked
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “TG-2349 (Furaprevir) is available as a Swedish orange capsule (size 0) for oral administration. Each capsule contains an equivalent of 100 mg of TG-2349 spray dried solid (SDD) and the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, magnesium stearate, and colloidal silicon oxide.”In the company’s words, NCT02340962 on ClinicalTrials.gov
- Tested for
- Chronic Hepatics C Virus (HCV) Genotype 1 (2 trials), Non-Cirrhotic (2 trials), Cirrhosis (2 trials), Treatment naïve (2 trials), Hepatitis C, Chronic
- Main trialPhase 3
- “A Phase III, Multicenter, open-labeded study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and Ribavirin for 12 weeks of treatment in HCV Genotype I Infected Patients”In the company’s words, NCT04155515 on ClinicalTrials.gov
Other drugs for Cirrhosis
- ElafibranorIpsen · Phase 3
- MosliciguatPulmovant, Inc. · Phase 3
- ResmetiromMadrigal Pharmaceuticals · Phase 3
- SC1011JOYO Pharma · Phase 2/3
- Saroglitazar MagnesiumZydus Therapeutics Inc. · Phase 3
- NerandomilastBoehringer Ingelheim · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 11 Aug 2020 | A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients | |
| Phase 2Completed | 12 Aug 2016 | Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection | |
| Phase 2Completed | 23 Apr 2019 | To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026